Healthcare

Botanix Pharmaceuticals Limited (ASX:BOT) addresses us dermatology commercialisation and specialty pharmacy access through its existing business activities. Commercial availability requires healthcare professionals to identify suitable patients and patients to obtain prescriptions through applicable dispensing channels. Coverage rules and patient costs can influence access, without …

Alterity Therapeutics Limited (ASX:ATH) addresses investigational therapy development in multiple system atrophy through its existing business activities. ATH434 is an investigational therapy. The biological rationale for an iron-targeting approach must be separated from evidence that a treatment provides meaningful benefit in patients. Clinical trial …

Amplia Therapeutics Limited (ASX:ATX) addresses narmafotinib manufacturing and pancreatic cancer studies through its existing business activities. Amplia reported transferring production from a research environment toward commercial-scale manufacturing. The company planned to convert the active pharmaceutical ingredient into capsules for clinical study use. Manufacturing readiness …

Conventional lateral-flow tests can require users to operate multiple components in a fixed sequence. Missing a step, transferring the wrong volume of blood or handling buffer incorrectly can affect the process. Atomo Diagnostics (ASX:AT1) addresses these practical challenges through devices that combine components and …

Cochlear Limited (ASX:COH) operates through its own product and service model. The Osia 3 supports compatible Osia implant recipients upgrading their external processor. Cochlear also reported in September 2026 that its fully implantable hearing technology research programme had accumulated more than one million hours …

Cleo Diagnostics Limited (ASX:COV) operates through its own product and service model. The company said it received its first batch of commercially manufactured pre-surgical test kits in September 2026, enabling analytical validation activities to begin. Screening for symptom-free individuals and testing women with an …

CSL Limited (ASX:CSL) operates through its own product and service model. CSL Behring connects plasma collection with fractionation, manufacturing and distribution of plasma-derived medicines. CSL Seqirus operates in influenza vaccines, while CSL also addressed challenges affecting the Vifor business in its 2026 reporting.